Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Not applicable Interventional Results available

Wearable Cardioverter Defibrillator in Hemodialysis Patients (WED-HED) Study

ClinicalTrials.gov ID: NCT02481206

Public ClinicalTrials.gov record NCT02481206. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 5, 2026, 11:11 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

A multi-center, prospective, randomized controlled clinical trial with 1:1 assignment of treatment and control. This study will evaluate the impact of wearable cardioverter defibrillator use on sudden cardiac death in incident hemodialysis patients. The study will enroll up to 2,600 subjects. A maximum of 200 sites in the USA will be used for enrollment.

Study identification

NCT ID
NCT02481206
Recruitment status
Terminated
Study type
Interventional
Phase
Not applicable
Lead sponsor
Zoll Medical Corporation
Industry
Enrollment
66 participants

Conditions and interventions

Eligibility (public fields only)

Age range
50 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 31, 2015
Primary completion
Nov 30, 2017
Completion
Nov 30, 2017
Last update posted
Jan 18, 2021

2015 – 2017

United States locations

U.S. sites
31
U.S. states
17
U.S. cities
31
Facility City State ZIP Site status
Not listed Corona California
Not listed Downey California
Not listed Escondido California
Not listed Los Angeles California
Not listed Sacramento California
Not listed San Dimas California
Not listed San Luis Obispo California
Not listed Whittier California
Not listed Stamford Connecticut
Not listed Hialeah Florida
Not listed Miami Florida
Not listed Pembroke Pines Florida
Not listed Winter Garden Florida
Not listed Albany Georgia
Not listed Columbus Georgia
Not listed Fort Wayne Indiana
Not listed Greenbelt Maryland
Not listed Detroit Michigan
Not listed Rochester Hills Michigan
Not listed Minneapolis Minnesota
Not listed Kansas City Missouri
Not listed Las Vegas Nevada
Not listed New Brunswick New Jersey
Not listed The Bronx New York
Not listed Durham North Carolina
Not listed Canton Ohio
Not listed Greenville South Carolina
Not listed Chattanooga Tennessee
Not listed Knoxville Tennessee
Not listed Houston Texas
Not listed San Antonio Texas

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02481206, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 18, 2021 · Synced Sep 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02481206 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →